JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on February 25, 2005 Originally published In Press as doi:10.1074/jbc.M412817200 on December 15, 2004 Originally published In Press as doi:10.1074/jbc.M412817200 on December 8, 2004 Originally published In Press as doi:10.1074/jbc.M412817200 on December 6, 2004
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
280/8/7317    most recent
M412817200v4
M412817200v3
M412817200v2
M412817200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Plotkin, L. I.
Right arrow Articles by Bellido, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Plotkin, L. I.
Right arrow Articles by Bellido, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print December 21, 2004
J. Biol. Chem, 10.1074/jbc.M412817200
Submitted on November 12, 2004
Revised on December 8, 2004
Accepted on December 6, 2004

Bisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular mechanisms downstream of ERK activation

Lilian I. Plotkin, J. Ignacio Aguirre, Stavroula Kousteni, Stavros C. Manolagas, and Teresita Bellido

Division of Endocrinology and Metabolism, University of Arkansas for Medical Sciences, Little Rock, AR 72205

Corresponding Author: tmbellido{at}uams.edu

Both estrogens and bisphosphonates attenuate osteocyte apoptosis by activating the extracellular signal regulated kinases (ERKs). However, whereas estrogens activate ERKs via an extranuclear function of the estrogen receptor, bisphosphonates do so by opening connexin 43 hemichannels. Here, we demonstrate that the signaling events downstream of ERKs induced by these two stimuli are also distinct. Inhibition of osteocyte apoptosis by estrogens requires nuclear accumulation of ERKs and activation of downstream transcription factors. On the other hand, anti-apoptosis induced by bisphosphonates requires neither transcription nor ERK-dependent transcription factors. Instead, the effect of bisphosphonates is abolished when ERKs are restricted to the nucleus by blocking CRM1/exportin1-mediated nuclear protein export or by expressing nuclear-anchored ERKs, but it is unaffected in cells expressing cytoplasmic-anchored ERKs. Connexin 43/ERK-mediated anti-apoptosis induced by bisphosphonates requires the kinase activity of the cytoplasmic target of ERKs, p90RSK, which in turn phosphorylates the pro-apoptotic protein BAD and C/EBP. Phosphorylation of BAD renders it inactive, whereas phosphorylation of C/EBP leads to binding of pro-caspases, thus inhibiting apoptosis independently of the transcriptional activity of this transcription factor. Consistent with the evidence that estrogens and bisphosphonates phosphorylate diverse targets of ERKs, probably resulting from activation of spatially distinct pools of these kinases, the two agents had additive effects on osteocyte survival.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J EndocrinolHome page
A. Vasconsuelo, L. Milanesi, and R. Boland
17{beta}-Estradiol abrogates apoptosis in murine skeletal muscle cells through estrogen receptors: role of the phosphatidylinositol 3-kinase/Akt pathway
J. Endocrinol., February 1, 2008; 196(2): 385 - 397.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. R. Hammes and E. R. Levin
Extranuclear Steroid Receptors: Nature and Actions
Endocr. Rev., December 1, 2007; 28(7): 726 - 741.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K. Horsch, H. de Wet, M. M. Schuurmans, F. Allie-Reid, A. C. B. Cato, J. Cunningham, J. M. Burrin, F. S. Hough, and P. A. Hulley
Mitogen-Activated Protein Kinase Phosphatase 1/Dual Specificity Phosphatase 1 Mediates Glucocorticoid Inhibition of Osteoblast Proliferation
Mol. Endocrinol., December 1, 2007; 21(12): 2929 - 2940.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. I. Aguirre, L. I. Plotkin, A. R. Gortazar, M. M. Millan, C. A. O'Brien, S. C. Manolagas, and T. Bellido
A Novel Ligand-independent Function of the Estrogen Receptor Is Essential for Osteocyte and Osteoblast Mechanotransduction
J. Biol. Chem., August 31, 2007; 282(35): 25501 - 25508.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. Huang, M. Khoe, M. Befekadu, S. Chung, Y. Takata, D. Ilic, and M. Bryer-Ash
Focal adhesion kinase mediates cell survival via NF-{kappa}B and ERK signaling pathways
Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1339 - C1352.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
R. G. G. Russell
Bisphosphonates: Mode of Action and Pharmacology
Pediatrics, March 1, 2007; 119(Supplement_2): S150 - S162.
[Abstract] [Full Text] [PDF]


Home page
IBMS BoneKEyHome page
M. R. McClung
Bisphosphonate Therapy: To Stop or Not to Stop?
IBMS BoneKEy, February 1, 2007; 4(2): 78 - 82.
[Full Text] [PDF]


Home page
J. Cell Sci.Home page
D. J. Chung, C. H. M. Castro, M. Watkins, J. P. Stains, M. Y. Chung, V. L. Szejnfeld, K. Willecke, M. Theis, and R. Civitelli
Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin43
J. Cell Sci., October 15, 2006; 119(20): 4187 - 4198.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Rodriguez-Sinovas, K. Boengler, A. Cabestrero, P. Gres, M. Morente, M. Ruiz-Meana, I. Konietzka, E. Miro, A. Totzeck, G. Heusch, et al.
Translocation of Connexin 43 to the Inner Mitochondrial Membrane of Cardiomyocytes Through the Heat Shock Protein 90-Dependent TOM Pathway and Its Importance for Cardioprotection
Circ. Res., July 7, 2006; 99(1): 93 - 101.
[Abstract] [Full Text] [PDF]


Home page
Sci Aging Knowl EnvironHome page
J. L. Carrington and F. L. Bellino
Developing a Research Agenda in Biogerontology: Physiological Systems
Sci. Aging Knowl. Environ., June 28, 2006; 2006(10): pe17 - pe17.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Almeida, L. Han, T. Bellido, S. C. Manolagas, and S. Kousteni
Wnt Proteins Prevent Apoptosis of Both Uncommitted Osteoblast Progenitors and Differentiated Osteoblasts by {beta}-Catenin-dependent and -independent Signaling Cascades Involving Src/ERK and Phosphatidylinositol 3-Kinase/AKT
J. Biol. Chem., December 16, 2005; 280(50): 41342 - 41351.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. I. Plotkin, I. Mathov, J. I. Aguirre, A. M. Parfitt, S. C. Manolagas, and T. Bellido
Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs
Am J Physiol Cell Physiol, September 1, 2005; 289(3): C633 - C643.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
E. R. Levin
Integration of the Extranuclear and Nuclear Actions of Estrogen
Mol. Endocrinol., August 1, 2005; 19(8): 1951 - 1959.
[Abstract] [Full Text] [PDF]


Home page
IBMS BoneKEyHome page
E. Seeman and G. J. Strewler
Clinical and Basic Research Papers - February 2005 Selections
IBMS BoneKEy, March 1, 2005; 2(3): 1 - 5.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.